Therapeutics

Develops methods of treating breast cancer with taxane therapy

Clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies

Privately held company engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies

Uses the power of CRISPR in the gut microbiome to treat chronic gastrointesttinal diseases

Develops novel oncology therapies

Developing first-in-class, next-generation recombinant enzyme and gene therapies for lysosomal storage disorders by unlocking the potential of mannose 6-phosphate (M6P)

Aims to operate in the cancer immunotherapy and nanotechnology-enabled drug delivery market by providing new targeted theragnostic opportunities for patients diagnosed with poor prognosis cancers

Aims to deliver the first FDA-approved anti-itch medication for CPUO and other chronic itch conditions

Developed adenovirus vaccines intended to cure infectious diseases

Dedicated to the health and well being of patients with central nervous system disorders